CERVIX | CERVICAL SCREENING [ISSN 1804-087X]
česky | english | sitemap


PARTNERS AND EXPERT GUARANTEE
 
Czech Gynaecological and Obstetrical Society | Ministry of Health | Institute of Biostatistics and Analyses, Masaryk University
GRANT SUPPORT OF THE PROJECT
 
GlaxoSmithKline     Roche |

Other sources of information
Cervical cytology (in Czech)www.cipek.cz
Cervical cytology
 
Cancer Screening in the European Unionec.europa.eu
Cancer Screening in the European Union (2017)
[ 10,6 MB]
 
SVOD - Epidemiology of malignant tumours in the Czech Republicwww.svod.cz
Epidemiology of malignant tumours
in the Czech Republic
 
NCI Bethesda System
HPV College

 

Results of personalised invitations of Czech citizens to cancer screening programmes in 2014

The project of personalised invitations of citizens to cancer screening programmes was launched in the Czech Republic in January 2014. Women are invited to participate in breast cancer screening and cervical cancer screening; men and women are invited to participate in colorectal cancer screening. The project aims to enhance the current cancer prevention programmes, and to increase their participation rates; therefore, personalised invitations are sent to citizens who do not participate in cancer screening programmes in the long term, and thus are at a higher risk of developing cancer.


The project is coordinated by the Czech Ministry of Health in cooperation with representatives of the relevant medical societies (gynaecology, gastroenterology, gastrointestinal oncology, diagnostic radiology, general medicine), representatives of health insurance companies, and other leading experts in the field. All health insurance companies invite their clients (persons insured) to participate in cancer screening programmes, reimbursing all examinations needed. The project is financially supported from the EU funds. 

“The Czech Republic ranks among countries with the highest cancer incidence rates worldwide. Each year more than 77,000 people are diagnosed with cancer in the Czech Republic, and there are almost 28,000 cancer deaths,” said Svatopluk Nemecek, Minister of Health of the Czech Republic. “By the end of 2013, the prevalence of cancer patients in the Czech Republic was more than 450,000 people. These alarming statistics clearly prove the need for effective cancer prevention. According to preliminary data, cancer was diagnosed in 602 patients within the screening programme. A vast majority of these findings have a very high chance of successful treatment.”

Since the start of the project, more than 2 million Czech citizens have been invited to attend preventive health checks. Personalised invitations as part of cancer screening programmes were launched in January 2014. The project aims to increase the participation rates in screening programmes, which are focused on the detection of breast cancer and cervical cancer in women, and colorectal cancer in men and women. Invitations are sent to citizens from high-risk age groups who have not undergone these preventive examinations yet. The project has been prepared and coordinated by the Czech Ministry of Health in cooperation with expert medical societies and health care payers (health insurance companies). Health insurance companies themselves send personalised invitations to their clients. Since March 2014, the project of personalised invitations has been supported by a nationwide health education campaign. The total budget of the project is approximately 107 million CZK, out of which 62 million CZK have been assigned to personalised invitations. The project has been financed mostly from the EU funds (85%), and partly from the state budget (15%). A total of 43,796,450 CZK were used in 2014.

The tables and charts below show the results of personalised invitations in the first twelve months of the project. Besides the Czech Ministry of Health, an independent evaluation of the results – based on data from health care payers – is also performed by the Institute of Biostatistics and Analyses of the Masaryk University. Results of this evaluation show that although hundreds of thousands of people have already participated in screening programmes, there is still a large proportion of people who have chosen not to attend these free-of-charge preventive health checks. The Czech Ministry of Health will therefore continue to support cancer prevention, mainly by personalised invitations and health education campaigns.

More information about individual cancer screening programmes is available at www.mamo.cz (breast cancer screening), www.kolorektum.cz (colorectal cancer screening), and www.cervix.cz (cervical cancer screening).

Cancer Screening Programmes in the Czech Republic

 

Results of personalised invitations in the Czech media

Press conference of the Czech Ministry of Health Hyde Park (Czech TV): Cancer prevention
videozáznam z tiskové konference MZ ČR (17. 4. 2015) Hyde Park (Česká televize), 17. 4. 2015

 

Results of personalised invitations in numbers

Table 1: Results of cancer screening programmes before the start of personalised invitations, and modelled results after the start of personalised invitations, all age groups.

Monitored period of organised screening
Cervical cancer (C53)
Breast cancer (C50)
Colorectal cancer (C18–C20)
2010–2013 2002–2013 2006–2013
Total number of performed screening examinations
8,411,969 cytology examinations 4,863,628 mammography examinations 3,559,558 FOBT
19,798 PSC
Number of patients with a positive result of screening examination* 19,405 patients with a cytological finding of precancerous lesion or carcinoma 24,994 patients with a finding of breast cancer 44,378 patients with a finding of adenoma
5,066 patients with a finding of carcinoma
* In the vast majority of these findings, there is a high chance of a complete cure.
Number of people coming as a result of personalised invitations
(2014 – preliminary data)
55,393 cytology examinations 70,082 mammography examinations 217,214 FOBT or PSC
Number of patients with a positive result of screening examination as a result of personalised invitations
(2014 – preliminary data)*
105 patients with a cytological finding of precancerous lesion or carcinoma 332 patients with a finding of breast cancer 4,170 patients with a finding of adenoma
165 patients with a finding of carcinoma
* In the vast majority of these findings, there is a high chance of a complete cure.

Abbreviations: FOBT = faecal occult blood test; PSC = primary screening colonoscopy
Source of data: Institute of Biostatistics and Analyses of the Masaryk University (cancer screening programmes), Czech National Reference Centre, health care payers

 

Table 2: Numbers of insured persons invited to individual cancer screening programmes during 2014 (invitations sent to a total of 1,959,504* persons).

Variant of the invitation letter Invitation to participate in
cervical cancer screening
breast cancer screening
colorectal cancer screening
Men invited to participate in colorectal cancer screening     783,151
Women invited to participate in cervical cancer screening 217,484    
Women invited to participate in breast cancer screening   126,962  
Women invited to participate in cervical and breast cancer screening 114,161 114,161  
Women invited to participate in colorectal cancer screening     391,152
Women invited to participate in cervical and colorectal cancer screening 46,350   46,350
Women invited to participate in breast and colorectal cancer screening   61,853 61,853
Women invited to participate in all cancer screening programmes 218,211 218,211 218,211
Total number of insured persons invited to cancer screening programmes 596,386 521,187 1,500,897

* The total number of invited persons does not correspond to the sum of numbers of invited persons to individual programmes, because many insured persons are invited to multiple programmes at the same time.

 

Table 3: Reactions of clients to cancer screening invitations – participation rate of persons invited in the first half of 2014.

Screening programme
Participation rate (%)
Cervical cancer screening 9.3
Breast cancer screening 13.4
Colorectal cancer screening 14.5

 

Table 4: Basic epidemiological characteristics of colorectal cancer, breast cancer in women, and cervical cancer in the Czech Republic in the period 2007–2011.1

Parameter Sex Colorectal cancer
(C18–C20)
Breast cancer
(C50) in women
Cervical cancer
(C53)
Incidence rates
Number of new cases per 100,000 population per year Men:
Women:
93.4
61.5

121.3

19.0
Absolute number of new cases per year

Men:
Women:

4,802
3,282

6,475

1,016
Proportion in the overall cancer incidence Men:
Women:
12.1 %
9.3 %

18.3 %

2.9 %
Trend in the period 2001–2011 Men:
Women:
+ 8 %
+ 2 %

+ 23 %

– 7.5 %
Typical age of patients (25th–75th percentile)

Occurrence men : women
Men:
Women:

 
61–76 years
62–79 years

1.5 : 1

54–73 years


40–64 years

Mortality rates2
Number of deaths per 100,000 population per year Men:
Women:
43.1
29.4

31.2

6.0
Absolute number of deaths per year Men:
Women:
2,122
1,565

1,725

315
Trend in the period 2001–2011   – 16 % – 14 % – 17 %
Proportion in the overall cancer mortality Men:
Women:
4.1 %
3.0 %

3.2 %

0.6 %
Prevalence rates
Survivors per 100,000 population
(as on 31 Dec 2011)
Men:
Women:
553.5
421.0

1,257.9

325.4
Absolute number of survivors
(as on 31 Dec 2011)
Men:
Women:
28,550
22,514

67,261

17,398
Trend in the period 2001–2011 Men:
Women:
+ 66 %
+ 52 %

+ 69 %

+ 25 %

1 Overall epidemiological burden, data involving all records on respective cancers including their diagnosis as another primary cancer in the same person. Source of Data: Czech National Cancer Registry
2 Source of data: Czech Statistical Office

Incidence = Number of newly diagnosed cancers per one year, expressed either as an absolute number of cases or as a rate per 100,000 persons (men or women).
Mortality = Number of cancer-related deaths per one year, expressed either as an absolute number of cancer-related deaths or as a rate per 100,000 persons (men or women).
Prevalence = Number of people who had received a diagnosis of cancer who were alive on 31 Dec 2011, expressed either as an absolute number of survivors or as a rate per 100,000 persons (men or women).

Personalised invitations of Czech citizens to cancer screening programmes: results of the year 2014
Fig. 1: Increase in the number of examinations in the Cervical Cancer Screening Programme
Fig. 1: Increase in the number of examinations in the Cervical Cancer Screening Programme
Fig. 2: Increase in the number of examinations in the Breast Cancer Screening Programme
Fig. 2: Increase in the number of examinations in the Breast Cancer Screening Programme
Fig. 3: Increase in the number of examinations in the Colorectal Cancer Screening Programme
Fig. 3: Increase in the number of examinations in the Colorectal Cancer Screening Programme
Fig. 4: Cervical cancer screening – response to invitations, according to age
Fig. 4: Cervical cancer screening – response to invitations, according to age
Fig. 5: Cervical cancer screening – response to invitations, according to region
Fig. 5: Cervical cancer screening – response to invitations, according to region
Fig. 6: Breast cancer screening – response to invitations, according to age
Fig. 6: Breast cancer screening – response to invitations, according to age
Fig. 7: Breast cancer screening – response to invitations, according to region
Fig. 7: Breast cancer screening – response to invitations, according to region
Fig. 8: Colorectal cancer screening – response to invitations, according to age
Fig. 8: Colorectal cancer screening – response to invitations, according to age
Fig. 9: Colorectal cancer screening – response to invitations, according to region
Fig. 9: Colorectal cancer screening – response to invitations, according to region
Fig. 10: Breast cancer (C50) epidemiology in the Czech Republic
Fig. 10: Breast cancer (C50) epidemiology in the Czech Republic
Fig. 11: Cervical cancer (C53) epidemiology in the Czech Republic
Fig. 11: Cervical cancer (C53) epidemiology in the Czech Republic
Fig. 12: Colorectal cancer (C18-C20) epidemiology in the Czech Republic (both sexes)
Fig. 12: Colorectal cancer (C18-C20) epidemiology in the Czech Republic (both sexes)
Fig. 13: Significant drop in Czech mortality rates for cancers covered with screening programmes
Fig. 13: Significant drop in Czech mortality rates for cancers covered with screening programmes
         

16.4.2015 Czech Ministry of Health, Institute of Biostatistics and Analyses of Masaryk University


Back